http://bmj.com/cgi/content/full/323/7308/318
|
|||||||
|
|
Howard Bauchner
a Agency for Healthcare Research and Quality, Rockville, MD
20852, USA, b Division of General Pediatrics, Department
of Pediatrics, Boston University School of Medicine, Boston, MA 02118, USA
Correspondence to: H Bauchner hbauchne@ahrq.gov
|
|
Methods
and results |
|
|
We reviewed all research reports related to child health (involving patients
<18 years, pregnant women, or clinicians providing care to
children) published in 1999 in five American journals (JAMA,
New England Journal of Medicine, Pediatrics, Journal of Pediatrics,
Archives of Pediatrics and Adolescent Medicine). Each report
was reviewed independently by two research assistants for any
statement about informed consent or ethics committee approval; if
either statement was present, the report was categorised as having
ethical approval. An article that referred to another publication for
more details was not reviewed. This approach has been used previously.2 All five
journals require studies with human participants to report ethical
approval. Reports not describing approval were reviewed again by an
investigator to ensure that errors in categorisation of the studies
had not been made. Studies were also categorised according to
design. The ethics committee at Boston University School of Medicine
judged that this project did not represent research involving human
subjects and did not require review.
The journals contained 561 research reports related to child health.
Overall, 340 (61%, range 53-66%) publications had ethical approval
(table). The proportion of studies reporting ethical approval was
dependent on the study type.
|
|
|
Comment |
|
|
Despite increasing concern about the protection of human subjects, 40% of papers
did not report ethical approval. These findings are particularly
unexpected, since all five journals explicitly ask authors to
document approval
24% of medical journals do not include
such instructions.3
Although we reviewed only American publications, we are not aware of
data showing that papers published in non-American journals report
ethical approval more frequently.
There are three possible explanations for the low proportion of papers that
do not report ethical approval. Approval may have been obtained, but
not reported
this situation is likely to be rare
and is inconsistent with instructions to authors. Random non-reporting
cannot explain differences between study types.
Investigators may have failed to obtain and report ethical approval because of
confusion about the requirements. Nearly all investigators obtained
approval for randomised controlled trials, a study design widely
recognised to require safeguards. However, researchers may not
realise that ethics committee approval and informed consent may be
required for studies that do not enrol participants or that use
large datasets. Some of the prospective cohort studies without
approval could have been considered to be quality improvement
projects (audits), and there is no consensus about
when such projects become research. The Institute of Medicine
recently said that the project represents research and approval is
necessary if the investigator intends to publish the findings.4 Some
researchers may have deliberately disregarded ethical approval
standards and laws. Such occurrences are likely to be rare, but they
are not inconceivable.
Unless we enhance our system of safeguards, an unethical study could be
published. While the primary responsibility for assuring ethical
conduct of research rests with investigators, peer review journals
should be more active in protecting human subjects.
We have four recommendations to prevent unethical research being published.
Just as every article has a list of authors, every research study
should include a statement regarding human subjects. Articles should
not refer to other publications for information regarding ethical
approval. If the investigators believe that the research does not
need to be reviewed by the ethics committee, the reason for
exemption should be provided (however, we believe that investigators
should not make such a decision). Investigators should document
approval from the ethics committee and whether informed consent was
obtained
as discussed previously,5 these
are not synonymous.
Protecting participants in clinical research is, and must remain, one of the
highest priorities of medicine. As the final conduit of most
biomedical research, peer review journals can play a greater role in
protecting human participants by ensuring that every report of
clinical research contains a statement about the participants' protection.
|
|
Acknowledgments |
The views expressed in this article are those of
the authors and not necessarily of Agency for Healthcare Research and Quality
or US Department of Health and Human Services. We thank Dr Helen Burstin
and Dr John Eisenberg for their review and comments, and our two
research assistants, Josh Bauchner and Ian Zinn, who were invaluable.
Contributors: HB and JS contributed to all aspects of this project,
including conception and design, data analysis, and writing of the paper. HB is
the guarantor.
|
|
Footnotes |
Funding: Institutional National Research Service Award and Faculty
Development Program Grant to Department of Pediatrics, Boston
University School of Medicine.
Competing interests: None declared.
|
|
References |
|
|
|
1. |
Rennie D, Yank V. Disclosure to the reader of
institutional review board approval and informed consent. JAMA 1997;
277: 922-923 |
|
2. |
Olde Rikker MGM, ten Have HAMJ, Hoefnagels WHL. Informed
consent in biomedical studies on aging: survey of four journals. BMJ
1996; 313: 1117 |
|
3. |
Amdur RJ, Biddle C. Institutional review board approval
and publication of human research results. JAMA 1997; 277: 909-914 |
|
4. |
Institute of Medicine. Protecting data privacy in
health services research. Washington, DC: National Academy Press, 2000. |
|
5. |
Smith R. Informed consent: the intricacies. BMJ
1997; 314: 1059 |
(Accepted 14 May 2001)
© BMJ 2001
ALL
INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR
GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE
KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED
AS PROVIDING MEDICAL OR LEGAL ADVICE. THE DECISION WHETHER OR NOT TO
VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU
ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.